TRIAL NAME Presenter NAME Article Reference
Picture of trial DEFINE the TRIAL ACRONYM
BACKGROUND Key points Points about why trial was made ADD PICTURE HERE
Clinical question WHAT IS THE CLINICAL QUESTION OF TRIAL? PICTURE
DESIGN Analysis: Where was it performed? N= ? Setting: Group 1 Group 2 Setting: Median follow-up: ? Primary outcome: __ Secondary outcomes: __
Population Inclusion Criteria Exclusion Criteria Key Points Contraindication to anticoagulation therapy Ineligible to undergo trials of ≥2 medications in either treatment strategy
Interventions Group 1 Group 2 (Placebo Control) DESCRIBE Group 2 (Placebo Control) Describe Any other key points re: interventions?
RESULTS
RESULTS
criticisms Criticism 1 Criticism 2 Criticism 3
Bottom line ONE LINER ON TAKE AWAY POINTS
Discussion questions Discussion question 1 Discussion question 2
Discussion ANSWERS Discussion question 1 Discussion question 2
BOARD-LIKE Question QUESTION What/When/Where/Who/Why_? _ 70 yo male __ PE: Labs: Imaging: (Adapted from MKSAP)
BOARD-LIKE Question QUESTION Educational Objective: _ Key Point: Point 1 Point 2 QUESTION What/When/Where/Who/Why_? _
CLINICAL PEARL Changes in guideline? How to apply to daily practice?
REFERENCES